Literature DB >> 12470990

The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.

Andrew Tutt1, Alan Ashworth.   

Abstract

The proteins encoded by the breast-cancer-susceptibility genes, BRCA1 and BRCA2, have recently been implicated in DNA-repair processes, thereby improving our understanding of how the loss of these genes contributes to cancer initiation and progression. It appears that the role of BRCA1 in DNA repair, which could involve the integration of several pathways, is broader than that of BRCA2. BRCA1 functions in the signalling of DNA damage and its repair by homologous recombination, nucleotide-excision repair and possibly non-homologous end-joining. BRCA2 has a more specific role in DNA repair, regulating the activity of RAD51, which is required for homologous recombination. An improved understanding of the interactions of BRCA1 and BRCA2 with other proteins in large macromolecular complexes is helping to reveal their exact role in DNA repair.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470990     DOI: 10.1016/s1471-4914(02)02434-6

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  88 in total

1.  Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.

Authors:  Da Yang; Sofia Khan; Yan Sun; Kenneth Hess; Ilya Shmulevich; Anil K Sood; Wei Zhang
Journal:  JAMA       Date:  2011-10-12       Impact factor: 56.272

2.  Functional characterization of a cancer causing mutation in human replication protein A.

Authors:  Cathy S Hass; Lokesh Gakhar; Marc S Wold
Journal:  Mol Cancer Res       Date:  2010-06-29       Impact factor: 5.852

3.  Discriminatory suppression of homologous recombination by p53.

Authors:  Sheng Yun; Chadwick Lie-A-Cheong; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

4.  Conference report--early cancer diagnosis: beating the odds.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-08-03

Review 5.  Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  David J Hughes
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

Review 6.  Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.

Authors:  Tessa G Steenbruggen; Mette S van Ramshorst; Marleen Kok; Sabine C Linn; Carolien H Smorenburg; Gabe S Sonke
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

7.  Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer.

Authors:  Jianping Lu; Di Wu; Chuanxing Li; Meng Zhou; Dapeng Hao
Journal:  J Mol Med (Berl)       Date:  2014-07-27       Impact factor: 4.599

8.  BRCA2 is required for neurogenesis and suppression of medulloblastoma.

Authors:  Pierre-Olivier Frappart; Youngsoo Lee; Jayne Lamont; Peter J McKinnon
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

9.  BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation.

Authors:  Dali Zong; Salomé Adam; Yifan Wang; Hiroyuki Sasanuma; Elsa Callén; Matilde Murga; Amanda Day; Michael J Kruhlak; Nancy Wong; Meagan Munro; Arnab Ray Chaudhuri; Baktiar Karim; Bing Xia; Shunichi Takeda; Neil Johnson; Daniel Durocher; André Nussenzweig
Journal:  Mol Cell       Date:  2019-01-28       Impact factor: 17.970

10.  Nuclear PARP1 expression and its prognostic significance in breast cancer patients.

Authors:  Annalisa Mazzotta; Giulia Partipilo; Simona De Summa; Francesco Giotta; Giovanni Simone; Anita Mangia
Journal:  Tumour Biol       Date:  2015-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.